Ultragenyx Pharmaceutical RARE
NASDAQ RARE
$15.64 -0.31 (-1.94%)
As of: Oct 23, 2026 · 3:59 PM EDT

Ultragenyx Pharmaceutical (RARE) Ending Cash Balance (2017 - 2020)

Updated

Analysis

Ultragenyx Pharmaceutical (RARE) Ending Cash Balance (2017 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 16.91 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.88 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 1.03 Bn
10 Ultragenyx Pharmaceutical 1.60 Bn -208.38 Mn 180.00 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 200.25 Mn
Mar 31, 2020 300.96 Mn
Dec 31, 2019 436.24 Mn
Sep 30, 2019 125.24 Mn
Jun 30, 2019 134.00 Mn
Mar 31, 2019 271.98 Mn
Dec 31, 2018 115.53 Mn
Sep 30, 2018 85.43 Mn
Jun 30, 2018 113.33 Mn
Mar 31, 2018 229.20 Mn
Dec 31, 2017 103.04 Mn
API Access

Ultragenyx Pharmaceutical Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=RARE&period=max&api_key=YOUR_API_KEY